Delivery Order SPE2DB20D3104-SPE2DB25FV5X4
Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,858.85 firm fixed-price contract is for the delivery of emtricitabine-tenofovir 200-300mg pharmaceutical products. The contract has an ultimate completion date of January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,790.82, is for the delivery of emtricitabine-tenofovir 200-300 mg medical supplies. This is a firm fixed-price contract with a completion date of March 11, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,689.89, is for the delivery of emtricitabine-tenofovir 200-300 mg medication, with a final completion date of February 27, 2025. The contract is a firm fixed-price delivery order, without any set-aside requirements. AmerisourceBergen holds a larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,350.48, is for the delivery of emtricitabine-tenofovir 200-300 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of November 30, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,960.81 on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Emtricitabine-Tenofovir 200-300mg tablets in a quantity of 30 units. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and was competitively awarded without set-aside designation. This delivery order...
- This delivery order contract, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 4,561,773,544 units of the HIV medication emtricitabine-tenofovir 200-300 mg. The $1,872.24 firm fixed price award has an ultimate completion date of August 11, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical...
- This is a delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,975.23 firm-fixed-price contract is for the delivery of pharmaceutical products, including emtricitabine-tenofovir 200-300 mg tablets, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is not associated...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,618.76, is for the delivery of emtricitabine-tenofovir 200-300 mg pharmaceutical products. It is a firm fixed-price contract with a period of performance through March 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $1,472.40, is for the delivery of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract is a firm fixed price delivery order with a completion date of February 23, 2024. No set-aside designation was used for this award....